Investigating Disease Mechanisms and Drug Response Differences in Transcriptomics Sequencing Data

dc.contributor.advisorLiu, Yunlong
dc.contributor.authorSimpson, Edward Ronald Jr.
dc.contributor.otherJanga, Sarath
dc.contributor.otherWan, Jun
dc.contributor.otherWu, Huanmei
dc.contributor.otherYan, Jingwen
dc.date.accessioned2022-02-09T13:12:58Z
dc.date.available2022-02-09T13:12:58Z
dc.date.issued2022-01
dc.degree.date2022en_US
dc.degree.discipline
dc.degree.grantorIndiana Universityen_US
dc.degree.levelPh.D.en_US
dc.descriptionIndiana University-Purdue University Indianapolis (IUPUI)en_US
dc.description.abstractIn eukaryotes, genetic information is encoded by DNA, transcribed to precursor messenger RNA (pre-mRNA), processed into mature messenger RNA (mRNA), and translated into functional proteins. Splicing of pre-mRNA is an important epigenetic process that alters the function of proteins through modifying the exon structure of mature mRNA transcripts and is known to greatly contribute to diversity of the human proteome. The vast majority of human genes are expressed through multiple transcript isoforms. Expression of genes through splicing of pre-mRNA plays crucial roles in cellular development, identity, and processes. Both the identity of genes selected for transcription and the specific transcript isoforms that are expressed are essential for normal cellular function. Deviations in gene expression or isoform proportion can be an indication or the cause of disease. RNA sequencing (RNAseq) is a high-throughput next-generation sequencing technology that allows for the interrogation of gene expression on a massive scale. RNAseq generates short sequences that reflect pieces of mRNAs present in a sample. RNAseq can therefore be used to explore differences in gene expression, reveal transcript isoform identities and compare changes in isoform proportions. In this dissertation, I design and apply advanced analysis techniques to RNAseq, phenotypic and drug response data to investigate disease mechanisms and drug sensitivity. Research Goals: The work described in this dissertation accomplishes 4 aims. Aim 1) Evaluate the gene expression signature of concussion in collegiate athletes and identify potential biomarkers for response and recovery. Aim 2) Implement a machine-learning algorithm to determine if splicing can predict drug response in cancer cell lines. Aim 3) Design a fast, scalable method to identify differentially spliced events related to cancer drug response. Aim 4) Construct a drug-splicing network and use a systems biology approach to search for similarities in underlying splicing events.en_US
dc.identifier.urihttps://hdl.handle.net/1805/27735
dc.identifier.urihttp://dx.doi.org/10.7912/C2/973
dc.language.isoen_USen_US
dc.subjectcanceren_US
dc.subjectconcussionen_US
dc.subjectdrug responseen_US
dc.subjectmachine learningen_US
dc.subjectnetworken_US
dc.subjectsplicingen_US
dc.titleInvestigating Disease Mechanisms and Drug Response Differences in Transcriptomics Sequencing Dataen_US
dc.typeDissertation
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Simpson_iupui_0104D_10562.pdf
Size:
2.65 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: